MoTing Medical Completes Nearly RMB 100 Million Series B Financing to Advance Ophthalmic Innovation and Global Expansion

News on April 8: Shenzhen Certainn Technology Co., Ltd. (referred to as "Moptim") announced the completion of a nearly 100-million-yuan B-round financing. This round of financing was led by China Venture Capital Co., Ltd., with existing shareholders Guoke Investment and BV Baidu Ventures making additional oversubscribed investments.

This round of funding will be used for the iteration of underlying optical core technologies, the expansion of high-end manufacturing capacity, the upgrade of AI algorithms, and the comprehensive promotion of product scaling in grassroots healthcare in China and global markets.

After this round of financing, Moptim will focus on three directions for high-quality development. Tackling core technologies: continuously breaking through key capabilities such as high resolution, high-speed scanning, and AI-assisted analysis to consolidate the self-developed core barriers in China; Expanding high-end intelligent manufacturing: enhancing the stability of the global supply chain and delivery capabilities to support synchronized growth in grassroots markets in China and the global market; Global layout: improving domestic and overseas channels and technical service systems to build a clinical support and market network covering the globe.